<DOC>
	<DOCNO>NCT00004329</DOCNO>
	<brief_summary>OBJECTIVES : I . Determine response plasma norepinephrine concentration plasma glycerol agonist ( clonidine ) antagonist ( yohimbine ) alpha-2 adrenergic receptor 6 patient regional lipoatrophy 6 control . II . Determine full sequence alpha-2 adrenergic receptor structural gene genomic DNA peripheral blood leukocyte .</brief_summary>
	<brief_title>Study Alpha-2 Adrenergic Receptor Dysfunction Regional Lipoatrophy</brief_title>
	<detailed_description>PROTOCOL OUTLINE : Antihypertensives hold , begin 3 day first study day . An oral challenge administer follow : clonidine day 1 , yohimbine day 2 . The order administration reverse alternate subject . Timed measurement norepinephrine , glycerol , free fatty acid follow challenge . Structural gene sequence evaluate participant .</detailed_description>
	<mesh_term>Lipodystrophy</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Clinical diagnosis regional lipoatrophy Control subject : Women age 18 65 Weight 90 % 150 % ideal No significant acute chronic illness Patient Characteristics Negative pregnancy test require fertile woman</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2003</verification_date>
	<keyword>endocrine disorder</keyword>
	<keyword>rare disease</keyword>
</DOC>